- STAT+: Prime Medicine claims victory in dispute over gene-editing technology with Beam TherapeuticsPrime Medicine said it had won an arbitration dispute against Beam Therapeutics, a clash that had pitted two well-backed gene-editing companies against each other.STAT · 17d ago↗ source
- STAT+: Pharmalittle: We’re reading about a Vera kidney drug approval, a U.K. Enhertu pricing deal, and moreThe FDA approved a kidney disease drug from Vera Therapeutics called Trutakna, to treat IgA nephropathySTAT · 18d ago↗ source
- Prime wins gene editing dispute; Saol claims latest post-Makary FDA reversal<figure><div><img src="https://imgproxy.divecdn.com/idsdMAHsPbXObDUtQW2qRG7uveBUVv6HCTn9NTtlDOI/g:nowe:0:0/c:1207:682/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0x…